Endoglin: Clinical Trials

4 trials of Endoglin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 2, Terminated 2

Follow Endoglin: new trials by email Literature Review of Endoglin trials Research Report on Endoglin

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant Beyond 3 Years of Use (MK-8415-060)
Radiopaque Etonogestrel (ENG) Implant - Contraception
Phase 3CompletedOrganon and Co4982020-11-192026-02-18
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059)
Etonogestrel (ENG) 125 μg + 17β-estradiol (E2) 300 μg vaginal ring, Placebo vaginal ring, Ibuprofen - Moderate to Severe Primary Dysmenorrhea
Phase 3TerminatedOrganon and Co252016-02-112024-05-28
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in the Treatment of Women With Primary Dysmenorrhea (MK-8342B-060)
ENG 125 μg + E2 300 μg vaginal ring (MK-8342B), Placebo vaginal ring, Ibuprofen - Dysmenorrhea
Phase 3TerminatedOrganon and Co182016-02-092024-05-28
A Study to Evaluate the Effectiveness of NuvaRing® to Prevent Pregnancies in Chinese Women (P06450)
ENG 120 µg + EE 15 µg intravaginal ring, DRSP 3 mg + EE 30 µg - Contraception
Phase 3CompletedOrganon and Co9832011-09-192024-06-20

Conditions studied

Dysmenorrhea (1)

Sponsors

Organon and Co (4)

Countries

Puerto Rico (1)  ·  United States (1)

Results publications

PMID 27339759

NIH funding

2015 (2)